Analysts expect IQM Quantum Computers (IQMX) to report a Q2 loss per share of $0.21, while revenue estimates center around $9.15 million as the company reports for the first time since its July 2026 Nasdaq listing. The key focus for investors is the successful delivery and deployment of full-stack superconducting systems, particularly the recently announced IQM Halocene units for research and HPC centers. Investors are also monitoring the company's path toward commercial scale following its pro forma cash injection of €337 million from its business combination.
Recent sentiment has been cautious, with the stock trading near $9.90—roughly 24% below its analyst target—amid sector-wide pressure on pre-profit quantum firms and a recent share-registration filing.